Forecyte Bio Limited is a CDMO company founded in 2021 to service the rapidly growing Cell and Gene Therapy (CGT) industry. Built on decades of experience and expertise from its core technical experts on CGT CMC processes, Forecyte Bio offers an integrated service package to accelerate CGT projects from early concept to IND filing and eventual commercial licensure and manufacturing. Our mission is to accelerate patient access to cell and gene therapy with quality, speed, and agility. - Process Development to GMP production - Preclinical to Commercial scale - CMC documentation for IND and BLA - Variety of Products . Plasmids . Viral Vectors (AAV, Adeno Virus, Lenti Virus, Oncolytic Virus) . Cell processing (CAR-T, TCR-T, and CAR-NK) - Extensive experience - Multiple Locations in US and China